Related Experiment Videos
c-fes expression in ontogenetic development and hematopoietic differentiation
A Carè1, G Mattia, E Montesoro
1Department of Hematology-Oncology, Istituto Superiore di Sanità, Rome, Italy.
Oncogene
|March 1, 1994
Summary
The c-fes protein kinase is expressed in developing tissues and hematopoietic stem cells, but not adult non-hematopoietic tissues. This suggests a role in embryonic development and blood cell differentiation.
Area of Science:
- Molecular Biology
- Developmental Biology
- Hematopoiesis
Background:
- The c-fes protein (NCP92) is a tyrosine-specific protein kinase involved in cellular signaling.
- Understanding c-fes expression patterns is crucial for elucidating its role in development and hematopoiesis.
Purpose of the Study:
- To analyze c-fes RNA expression during human/murine ontogenetic development.
- To investigate c-fes expression in embryonic and adult human hematopoietic cells.
Main Methods:
- Analysis of c-fes RNA expression using Northern blotting or similar techniques.
- Isolation and purification of hematopoietic progenitor cells from embryonic-fetal liver and adult peripheral blood.
- Differentiation of progenitor cells along erythroid and granulomonocytic lineages.
Main Results:
- c-fes expression was detected in rapidly proliferating embryonic-fetal tissues from various germinal layers.
- Spatially and temporally regulated c-fes transcription was observed in the central nervous system and developing cartilage.
- In hematopoietic cells, c-fes was abundant in undifferentiated progenitors and granulomonocytic precursors, but absent in erythroblasts.
- Expression patterns correlated with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) receptors.
Conclusions:
- c-fes plays a potential role in signal transduction during embryonic development in non-hematopoietic tissues.
- c-fes may be involved in the differentiation of hematopoietic cells, particularly along the granulomonocytic lineage.
- The findings suggest c-fes functions in response to growth factor signaling through tyrosine-kinase-negative receptors.